December 1, 2025 - 19:01

Researchers from the University of Michigan emphasize the critical need for robust governance in the development of small modular reactors (SMRs). As the nuclear industry explores new technologies, the study highlights the importance of implementing policies that prioritize public interest. The researchers warn that without appropriate oversight, the introduction of SMRs could lead to a repetition of past issues that have plagued the nuclear sector.
The potential of SMRs to provide cleaner energy and enhance energy security is significant. However, the study advocates for a comprehensive regulatory framework to mitigate risks associated with nuclear power. This includes addressing safety concerns, environmental impacts, and economic implications. The researchers argue that effective governance will not only ensure the safe operation of these reactors but also foster public trust and acceptance.
In conclusion, as the nuclear industry moves forward with innovative technologies, it is essential to learn from historical challenges and establish strong governance to safeguard the public interest.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...